FMT
CYTK icon

First Mercantile Trust’s Cytokinetics CYTK Stock Holding History

First Mercantile Trust’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$86K Buy
+2,417
New +$71.2K 0.01% 700
2020
Q3 		– Sell
-4,396
Closed -$104K – 861
2020
Q2 		$104K Buy
+4,396
New +$82.4K 0.01% 646

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

First Mercantile Trust's CYTK Position: Q3 2021 in Review

First Mercantile Trust opened a new position in Cytokinetics (CYTK) in Q3 2021: 2,417 shares worth $86K. The stake represents 0.01% of the portfolio and ranks #700 among its holdings. This is a return to the name: First Mercantile Trust previously reported a position in CYTK as recently as Q2 2020.

First Mercantile Trust first reported a position in CYTK in Q2 2020 and has held it in 2 quarters since. The position peaked at $104K in Q2 2020. 211 funds tracked by Wall St. Rank hold CYTK as of Q3 2021.

  • First Mercantile Trust held 2,417 shares of Cytokinetics worth $86K as of Q3 2021.
  • Cytokinetics was a new First Mercantile Trust position in Q3 2021.
  • Cytokinetics made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #700 holding.
  • First Mercantile Trust first reported a position in Cytokinetics in Q2 2020 and has held it in 2 quarters since.
  • First Mercantile Trust's Cytokinetics position peaked at $104K in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.